E 1.Initial reporter phone: (b)(6).E 1.Initial reporter address line 1: (b)(6).The device was returned to biosense webster (bwi) for evaluation.Visual inspection and screening tests of the returned device were performed following bwi procedures.Visual analysis revealed that there was a reddish material and a cut on the pebax's surface.The damage observed could be related to the manipulation of the device during the procedure, however, this cannot be conclusively determined.A screening test was performed, and the device was recognized; however, high force appeared due to the damage on the pebax.A manufacturing record evaluation was performed for the finished device number lot 31061646l and no internal actions related to the complaint were found during the review.The force issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.The instructions for use (ifu) contain the following recommendations: to ensure accurate force readings, verify that the force reading is near zero when the catheter is not in contact with tissue.If the force reading is not near zero when the catheter is not in contact with tissue, perform zeroing.If the force problem persists, replace the catheter cable or the catheter.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent a cardiac ablation procedure with a qdot micro¿ catheter for which biosense webster¿s product analysis lab (pal) identified a cut on the pebax's surface.Initially, it was reported that there was contact force issue during ablation.They changed the cable with no resolution.When the catheter was replaced, the issue was solved.The procedure was completed without patient consequence.The force issue was assessed as non mdr reportable.The potential risk that it could cause or contribute to a serious injury or death to the operator or patient was remote.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 28-nov-2023, there was a reddish material and a cut on the pebax's surface.The cut on the pebax was assessed as mdr reportable.The awareness date for this reportable lab finding was 28-nov-2023.
|